Regulatory News
Thursday, June 30, 2016
Mylan offers EC concessions to get approval for $7.2 bln Meda buy
BRUSSELS, June 30 - U.S. generic drugmaker Mylan NV
has offered concessions in a bid to allay concerns by EU
competition regulators over its proposed $7.2-billion
acquisition of Swedish rival Meda,...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment